Predicting the risk of venous thromboembolism during neoadjuvant therapy for oesophagogastric cancer

被引：0
|
作者：
Calabrese, Michele [1 ]
Chmelo, Jakub [1 ]
Prasad, Pooja [1 ]
Brown, Joshua [1 ]
Wallace, Lauren [1 ]
Phillips, Alexander [1 ]
机构：
[1] Royal Victoria Infirm, Northern Oesophago Gastr Unit, Newcastle Upon Tyne, Tyne & Wear, England
来源：
BRITISH JOURNAL OF SURGERY | 2021年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P-OGC60
引用
收藏
页数：1
相关论文
共 50 条
  • [31] NEOADJUVANT THERAPY ELEVATES THE RISK OF THROMBOEMBOLISM IN COLORECTAL CANCER PATIENTS.
    Smart, P.
    Burbury, K.
    Rose, W.
    Lynch, A.
    Mackay, J.
    Heriot, A.
    DISEASES OF THE COLON & RECTUM, 2013, 56 (04) : E199 - E199
  • [32] Extended Venous Thromboembolism Prophylaxis in Postoperative Oesophagogastric Cancer Patients: A Completed Audit
    Kuan, Jen Yee
    Turner, Paul
    Pursnani, Kishore
    Ward, Jeremy
    Shetty, Vinutha Daya
    BRITISH JOURNAL OF SURGERY, 2024, 111
  • [33] Predicting the risk of recurrent venous thromboembolism The Austrian Study on Recurrent Venous Thromboembolism (AUREC)
    Kyrle, P. A.
    Eischer, L.
    HAMOSTASEOLOGIE, 2013, 33 (03): : 201 - +
  • [34] Risk factors for venous thromboembolism in patients undergoing neoadjuvant chemotherapy as treatment for ovarian cancer
    Ward, Alistair
    Dampali, Roxani
    Wang, Wanxin
    Sclavi, Sofia Bertoni
    Khalil, Habib R.
    Touloumis, Anestis
    Devaja, Omer
    Papadopoulos, Andreas J.
    Montalto, Stephen Attard
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2025, 305 : 292 - 297
  • [35] Incidence and Risk of Venous Thromboembolism in Patients With Resectable Pancreatic Cancer Receiving Neoadjuvant Chemotherapy
    Kamiya, Mariko
    Kawahara, Shinnosuke
    Kamioka, Yuto
    Murakawa, Masaaki
    Aoyama, Toru
    Kobayashi, Satoshi
    Ueno, Makoto
    Yamamoto, Naoto
    Oshima, Takashi
    Yukawa, Norio
    Rino, Yasushi
    Masuda, Munetaka
    Morinaga, Soichiro
    ANTICANCER RESEARCH, 2023, 43 (04) : 1741 - 1747
  • [36] Risk Factors for venous thromboembolism in patients undergoing neoadjuvant chemotherapy as treatment for ovarian cancer
    Ward, A.
    Dampali, R.
    Khalil, H.
    Touloumis, A.
    Devaja, O.
    Papodopoulos, A.
    Attard-Montalto, S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 60 - 60
  • [37] Predicting venous thromboembolism (VTE) risk in cancer patients using machine learning
    Townsley, Samir Khan
    Basu, Debraj
    Vora, Jayneel
    Wun, Ted
    Chuah, Chen-Nee
    Shankar, Prabhu R. V.
    HEALTH CARE SCIENCE, 2023, 2 (04): : 205 - 222
  • [38] Predicting recurrent venous thromboembolism in cancer: is it possible?
    Kyrle, Paul A.
    THROMBOSIS RESEARCH, 2014, 133 : S17 - S22
  • [39] Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study
    van Es, Nick
    Louzada, Martha
    Carrier, Marc
    Tagalakis, Vicky
    Gross, Peter L.
    Shivakumar, Sudeep
    Rodger, Marc A.
    Wells, Philip S.
    THROMBOSIS RESEARCH, 2018, 163 : 41 - 46
  • [40] Cost-Effectiveness of Venous Thromboembolism Prophylaxis During Neoadjuvant Chemotherapy for ovarian Cancer
    Ryan, Emma S.
    Havrilesky, Laura J.
    Salinaro, Julia R.
    Davidson, Brittany A.
    JCO ONCOLOGY PRACTICE, 2021, 17 (08) : E1075 - E1084
12345